Moreover, the observed levels of CDK1 and CDK2 in Gadd45a-silenced cells following lenvatinib treatment were consistent with the aforementioned results (Fig. 5d), indicating that lenvatinib inhibits ICC cell proliferation via Gadd45a-mediated cell cycle arrest (Fig. 6). The gene discussed is CDK2; the disease is intrahepatic cholangiocarcinoma.